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Abstract
Background: The novel coronavirus SARS-19 produces ‘COVID-19’ in patients with symptoms. COVID-19 patients
admitted to the hospital require early assessment and care including isolation. The National Early Warning Score
(NEWS) and its updated version NEWS2 is a simple physiological scoring system used in hospitals, which may be
useful in the early identification of COVID-19 patients. We investigate the performance of multiple enhanced
NEWS2 models in predicting the risk of COVID-19.
Methods: Our cohort included unplanned adult medical admissions discharged over 3 months (11 March 2020 to
13 June 2020 ) from two hospitals (YH for model development; SH for external model validation). We used logistic
regression to build multiple prediction models for the risk of COVID-19 using the first electronically recorded
NEWS2 within ± 24 hours of admission. Model M0’ included NEWS2; model M1’ included NEWS2 + age + sex, and
model M2’ extends model M1’ with subcomponents of NEWS2 (including diastolic blood pressure + oxygen flow
rate + oxygen scale). Model performance was evaluated according to discrimination (c statistic), calibration
(graphically), and clinical usefulness at NEWS2 ≥ 5.
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Results: The prevalence of COVID-19 was higher in SH (11.0 %=277/2520) than YH (8.7 %=343/3924) with a higher
first NEWS2 scores ( SH 3.2 vs YH 2.8) but similar in-hospital mortality (SH 8.4 % vs YH 8.2 %). The c-statistics for
predicting the risk of COVID-19 for models M0’,M1’,M2’ in the development dataset were: M0’: 0.71 (95 %CI 0.68–
0.74); M1’: 0.67 (95 %CI 0.64–0.70) and M2’: 0.78 (95 %CI 0.75–0.80)). For the validation datasets the c-statistics were:
M0’ 0.65 (95 %CI 0.61–0.68); M1’: 0.67 (95 %CI 0.64–0.70) and M2’: 0.72 (95 %CI 0.69–0.75) ). The calibration slope
was similar across all models but Model M2’ had the highest sensitivity (M0’ 44 % (95 %CI 38-50 %); M1’ 53 %
(95 %CI 47-59 %) and M2’: 57 % (95 %CI 51-63 %)) and specificity (M0’ 75 % (95 %CI 73-77 %); M1’ 72 % (95 %CI 70-
74 %) and M2’: 76 % (95 %CI 74-78 %)) for the validation dataset at NEWS2 ≥ 5.
Conclusions: Model M2’ appears to be reasonably accurate for predicting the risk of COVID-19. It may be clinically
useful as an early warning system at the time of admission especially to triage large numbers of unplanned hospital
admissions.
Keywords: Vital signs, National early warning score, Emergency admission, Novel coronavirus SARS-19, Computer-
aided national early warning score
Introduction
The novel coronavirus SARS-19 produces the newly
identified disease ‘COVID-19’ in patients with symptoms
(Coronaviridae Study Group of the International Com-
mittee on Taxonomy of Viruses [1]) which was declared
as a pandemic on 11-March-2020 that has challenged
healthcare systems worldwide.
COVID-19 patients admitted to hospital can de-
velop severe disease with life-threatening respiratory
and/or multi-organ failure [2, 3] with a high risk of
mortality in part due to the lack of effective treat-
ment for the underlying disease in the early phase of
the pandemic. The appropriate early assessment and
management of patients with COVID-19 is important
in ensuring high-quality care including isolation, es-
calation to critical care or palliative care. Early assess-
ment of the risk of COVID-19 is crucial to this
process. Presently this involves clinical judgment
based on the patients presenting history, signs and
symptoms and viral nucleic acid testing can have a
24-hour turnaround time [4].
In England, the patient’s vital signs are monitored and
summarised into a National Early Warning Score
(NEWS) [5]. NEWS has gained widespread interest from
across the world, including Europe, India, the USA (and
the US Navy) [6]. NEWS offers a standardised approach
to assessing acute illness and is derived from seven
physiological variables or vital signs – respiration rate, oxy-
gen saturations, any supplemental oxygen, temperature,
systolic blood pressure, heart rate and level of conscious-
ness (Alert (A), Voice (V), Pain (P), Unresponsive (U)) –
which are routinely collected by nursing staff as an integral
part of the process of care.
In December 2017, an update to NEWS (NEWS2) was
published [6] that extends the level of consciousness
from AVPU to ACVPU, where C represents new confu-
sion or delirium and is allocated 3 points (the maximum
for a single variable). NEWS2 also offers two scales for
oxygen saturation (scale 1 and scale 2) which accommo-
dates patients with hypercapnic respiratory failure who
have clinically recommended oxygen saturation of 88–
92 %.
We posit that NEWS and NEWS2, and their subcom-
ponents, may be useful in predicting COVID-19 risk. So
we investigate the performance of multiple enhanced
NEWS and NEWS2 models in terms of discrimination
and calibration in predicting the risk of COVID-19. We
are using the first electronically recorded NEWS and
NEWS2 datasets and are available within 24 h of admis-
sion. This means that the models we investigate require
no additional data collection from staff and can be read-
ily automated in electronic health records.
Methods
Setting and data
Our cohorts of unplanned medical admissions are from
two acute hospitals which are approximately 65 km apart
in the Yorkshire and the Humber region of England –
Scarborough hospital (SH) (n ~ 300 beds) and York Hos-
pital (YH) (n ~ 700 beds), managed by York Teaching
Hospitals NHS Foundation Trust. We selected these hos-
pitals because they had electronically recorded NEWS2
scores, which are collected as an integral part of the pa-
tient’s process of care and were agreeable to the study.
Since NEWS is a subset of NEWS2, we developed NEWS
and NEWS2 based models because NEWS is still in wide-
spread use.
We included all consecutive adult (age ≥ 18 years) un-
planned medical admissions discharged during 3 months
(11 March 2020 to 13 June 2020), with electronic
NEWS2 data. For each admission, we obtained a pseu-
donymised patient identifier, patient’s age (years), sex
(male/female), discharge status (alive/dead), admission
and discharge date and time, diagnoses codes based on
the 10th revision of the International Statistical
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Classification of Diseases (ICD-10), NEWS2 (including
its subcomponents respiratory rate, temperature, systolic
pressure, pulse rate, oxygen saturation, oxygen supple-
mentation, oxygen scales 2 (yes/no), and alertness in-
cluding confusion). The diastolic blood pressure was
recorded at the same time as systolic blood pressure.
Historically, diastolic blood pressure has always been a
routinely collected physiological variable on vital sign
charts and is still collected where electronic observations
are in place. Since NEWS is a subset of NEWS2, we de-
rived NEWS from NEWS2. NEWS and NEWS2 produce
integer values that range from 0 (indicating the lowest
severity of illness) to 20 (the maximum NEWS2 value
possible) (see Supplemental Digital Content - Table S1
and S2). The index NEWS/NEWS2 was defined as the
first electronically recorded NEWS/NEWS2 within ±
24 h of the admission time. We excluded records where
the index NEWS/NEWS2 was not within ± 24 h or was
missing/not recorded at all (see Supplemental Digital
Content - Table S3). We searched primary and second-
ary ICD-10 codes for ‘U071’ for identifying COVID-19.
Although we used the ICD-10 code ‘U071’ to identify re-
cords with COVID-19, it is in 95 % agreement with poly-
merase chain reaction (PCR) swab tests result.
Statistical analyses
We began with exploratory analyses including box plots
that showed the relationship between covariates and risk
of COVID-19 and line plots showed the relationship be-
tween age, vital signs, NEWS2 and risk of COVID-19.
We developed three logistic regression models based on
NEWS and NEWS2 separately for predicting the risk of
COVID-19. The NEWS2-based models (M0’, M1’, M2’)
use the index or first electronically recorded NEWS2
dataset within ± 24 h of admission. Model M0’ uses
NEWS2 alone; Model M1’ extends M0’ with age and sex
and Model M2’ extends M1’ with all the subcomponents
of NEWS2 plus diastolic blood pressure. Equivalent
models (M0, M1, M2) using NEWS were also developed
but model M2 excluded two parameters that are in
NEWS2 but no in NEWS - oxygen flow rate and scale 2
(yes/no). A log-transformation was used for variables
with right-skewed distributions, i.e. for respiratory rate,
pulse rate, systolic and diastolic blood pressure.
We developed all models using YH data (as develop-
ment dataset) and externally validated their performance
on SH data (as validation dataset).
We report discrimination and calibration statistics as
performance measures for these models [7].
Discrimination relates to how well a model can separ-
ate, (or discriminate) between patients with and without
COVID-19 and is given by the area under the Receiver
Operating Characteristics (ROC) curve (AUC) or c-
statistic. The ROC curve is a plot of the sensitivity, (true
positive rate), versus 1-specificity, (false positive rate),
for consecutive predicted risks. A c-statistic of 0.5 is no
better than tossing a coin, whilst a perfect model has a
c-statistic of 1. In general, values less than 0.7 are con-
sidered to show poor discrimination, values of 0.7 to 0.8
can be described as reasonable, and values above 0.8
suggest good discrimination [8]. The 95 % confidence
interval for the c-statistic was derived using DeLong’s
method as implemented in the pROC library [9] in R
[10]. Calibration is the relationship between the ob-
served and predicted risk of COVID-19 (24) and can be
readily seen on a scatter plot (y-axis observed risk, x-axis
predicted risk). Perfect predictions should be on the 45°
line.
The predictive model performance is usually overesti-
mated if the same data is used for testing model per-
formance. There are several internal validation methods,
which aimed to provide a more accurate estimate of pre-
dictive model performance. We used bootstrapping as
an internal validation approach to assess the discrimin-
ation and calibration for all the models [11, 12]. The
overall statistical performance was assessed using the
scaled Brier score which simultaneously incorporates
discrimination and calibration [7]. The Brier score is the
squared difference between actual outcomes and pre-
dicted risk of COVID-19, scaled by the maximum Brier
score such that the scaled Brier score ranges from 0 to
100 %. Higher Brier scores indicate superior models. We
further assess discrimination and calibration-in-the-large
and calibration slopes in the validation data.
The clinical cut-off of NEWS and NEWS2 is 5+ (Sup-
plemental Digital Content - Figure S1). This is the rec-
ommended threshold for detecting deteriorating patients
and sepsis [13, 14]. Therefore, we assessed the sensitiv-
ity, specificity, positive and negative predictive values
and likelihood ratios for these models at NEWS/NEWS2
thresholds of 5+ [15]. We further compared the net
benefit for all models, which may inform the utility of
the models in routine clinical practice [16]. The net
benefit is calculated at a particular threshold probability







The model with the highest net benefit metric has the
highest clinical value.
We calculated the minimum sample size using the R
package pmsampsize [17]. We found 930 (93 events) is
the minimum required sample size with number of pre-
dictors = 21, R2 = 0.182, prevalence = 0.10, shrinkage >
0.9, margin absolute prediction error (MAPE) = 0.05
[18]. We followed the TRIPOD guidelines for reporting
model development and validation [19]. We have
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deployed our best performing models - M2’ and M2 - as
a calculator for predicting the risk of COVID-19 https://
covidcalc.shinyapps.io/calc/. We used Stata [20] for data
cleaning and R [10] for statistical analysis.
Results
Cohort characteristics
The number of unplanned discharges was 6444 over 3
months. We excluded 36 (0.6 %) records because the
index NEWS2 was not recorded within ± 24 h of the ad-
mission time or no recorded at all (see Supplemental
Digital Content - Table S3).
The characteristics of the admissions included in our
study are shown in Table 1. Emergency admissions in
the validation dataset were older than those in the devel-
opment dataset (69.6 years vs. 67.4 years), less likely to
be male (49.5 % vs. 51.2 %), had higher index NEWS (2.8
vs. 2.5) and NEWS2 (3.2 vs. 2.8) scores, higher preva-
lence of COVID-19 (11.0 % vs. 8.7 %) but similar in-
hospital mortality (8.4 % vs. 8.2 %). See accompanying
scatter and boxplots in Supplemental Digital Content -
Figure S2, S3, S4 and S5.
We assessed the performance of all models in predict-
ing the risk of COVID-19 in emergency medical admis-
sions (see Table 2 and Fig. 1). The c-statistics for
predicting COVID-19 for Model M2’ was the best in
class in the development dataset (M0’=0.71; M1’=0.72,
M2’: 0.78) (see Table S4 in supplementary material) and
the validation dataset (M0’=0.65; M1’=0.67, M2’: 0.72)
(see Table 2). The c-statistics for predicting COVID-19
for M0’,M1’,M2’ models was similar to M0,M1,M2
models in the development and validation datasets. Fur-
thermore, all models are shown statistically significant
improvement using likelihood ratio tests (see Table S5
in supplementary material).
Table 3 includes the sensitivity, specificity, positive
and negative predictive values for all models for predict-
ing COVID-19 for validation dataset. NEWS2 models
(M0’,M1’,M2’) had the highest sensitivity but lower spe-
cificity compared to NEWS models (M0,M1,M2) be-
cause the predicted probability at NEWS2 ≥ 5 (0.116) is
lower than at NEWS ≥ 5 (0.13) in the development data-
set. Likewise, the performance for development dataset
is shown in Table S6.
Internal validation of these models is shown in Supple-
mental Digital Content - Figure S6.
The calibration slope was similar and less than one
across all NEWS2 (M0’,M1’,M2’) and NEWS (M0,M1,M2)
models, which shows overfitting (see Table 2; Fig. 1; Sup-
plemental Digital Content - Table S4 & Figure S7).
However, model M2’ had the highest sensitivity (M2’:
57 % (95 %CI 51-63 %) vs. M0’ 44 % (95 %CI 38-50 %)
and M1’ 53 % (95 %CI 47-59 %)) and the highest specifi-
city (M2’:76 % (95 %CI 74-78 %) vs. M0’:75 % (95 %CI
73-77 %) and M1’:72 % (95 %CI 70-74 %)) for the valid-
ation dataset at NEWS2 ≥ 5 (see Table 3).
Likewise, model M2 had the highest sensitivity (M2:
52 % (95 %CI 46-58 %) vs. M0:33 % (95 %CI 27-38 %)
and M1:44 % (95 %CI 38-50 %)) but lowest specificity
(M2: 79 % (95 %CI 77-81 %) vs. M0:83 % (95 %CI 81-
85 %) and M1:79 % (95 %CI 77-80 %)) for the validation
dataset at NEWS2 ≥ 5 (see Table 3).
Figures 2 and 3 show model calibration improved
across the models and that models M2’ and M2 are
well-calibrated after correcting for the baseline
difference.
Table 1 Characteristics of emergency medical admissions
discharged during 3 months in development and validation






Male (%) 2010 (51.2) 1247 (49.5)
Mean Age [years] (SD) 67.4 (18.7) 69.6 (18.9)
Median Length of Stay
(days) (IQR)
3.0 (5.8) 3.7 (6.1)
COVID-19 (%) 343 (8.7) 277 (11.0)
Mortality
Mortality with-in 24 h (%) 30 (0.8) 32 (1.3)
Mortality with-in 48 h (%) 61 (1.6) 48 (1.9)
Mortality with-in 72 h (%) 96 (2.4) 68 (2.7)
In-hospital Mortality 323 (8.2) 212 (8.4)
Mean NEWS (SD) 2.5 (2.3) 2.8 (2.4)
Mean NEWS2 (SD) 2.8 (2.8) 3.2 (2.8)
Vital Signs
Mean Respiratory rate [breaths
per minute] (SD)
19.8 (5.1) 20.7 (5.6)
Mean Temperature [oC] (SD) 36.4 (0.9) 36.3 (1)
Mean Systolic pressure [mmHg] (SD) 141.8 (29.2) 142 (28.5)
Mean Diastolic pressure [mmHg] (SD) 79.2 (16.5) 79 (17.3)
Mean Pulse rate [beats per minute]
(SD)
89.1 (22.3) 88.5 (22.1)
Mean Oxygen saturation (SD) 96.3 (3.1) 96.1 (3.2)
Oxygen supplementation (%) 512 (13) 362 (14.4)
Mean oxygen flow rate (units) (SD) 7.1 (5.7) 6.1 (5.3)
Oxygen scale 2 (yes) (%) 240 (6.1) 163 (6.5)
Alertness
Alert (%) 3510 (89.4) 2243 (89)
Baseline confusion (%) 27 (0.7) 23 (0.9)
New confusion (%) 61 (1.6) 40 (1.6)
Pain (%) 32 (0.8) 17 (0.7)
Voice (%) 151 (3.8) 134 (5.3)
Unconscious (%) 143 (3.6) 63 (2.5)
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Figure 4 shows that model M2’/M2 had the highest
net benefit (M2’/M2:0.04 vs. M1’/M1:0.03 and M0’/M0:
0.02). As the unit of net benefit is true positives, the
model M2’/M2 identified 4 out of 100 COVID-19 ad-
missions, compared to M1’/M1 (3 out of 100) and M0’/
M0 (2 out of 100) (see Supplemental Digital Content -
Figure S8 for development dataset).
Nevertheless, NEWS/NEWS2 ≥ 5 is the worst perform-
ing choice compared to all models (NEWS2: M0’,M1’,M2’
& NEWS: M0,M1,M2).
Discussion
In this study, we investigated the performance of
multiple enhanced NEWS2 models in terms of
discrimination and calibration in predicting the risk
of COVID-19. Model M0’ uses NEWS2 alone; Model
M1’ extends M0’ with age and sex and Model M2’
extends M1’ with all the subcomponents of NEWS2
plus diastolic blood pressure. Equivalent models (M0,
M1, M2) using NEWS were also developed but
model M2 excluded two parameters that are in
NEWS2 but not in NEWS - oxygen flow rate and
scale 2 (yes/no).
NEWS2 models (M0’, M1’, M2’) were more sensitive
but less specific than NEWS models (M0, M1, M2).
Models M2 and M2’ were the best in class, with the
highest c-statistics (0.77 and 0.72 respectively). The high
negative predictive value suggests models M2 and M2’
may be particularly useful in ruling out COVID-19 early
in the patients unplanned admission which is clinically
useful because testing for COVID-19 using viral nucleic
acid testing is more time consuming than measuring
and recording the patients vital signs data sets as defined
by NEWS/NEWS2.
A recent systematic review identified five models to
detect COVID-19 infection in symptomatic individuals
with c-statistics that ranged from 0.87 to 1 [21]. How-
ever, despite these high c-statistics, the review authors
cautioned against the use of these models in clinical
practice because of the high risk of bias and poor report-
ing of studies which are likely to have led to optimistic
results [21]. For example, the majority of studies are
with smaller sample size; the lack of external validation
and calibration was rarely assessed [21]. Our study ad-
dresses these shortcomings. While most of the studies re-
ported an insufficient sample size [21], our study was
sufficiently large for developing and validating the models
in predicting the risk of COVID-19 [18]. The models were
developed using data from one and validated using data
from another hospital. We rigorously assessed the internal
calibration using bootstrapping approach [22]. Further-
more, calibration slope and calibration-in-the-large are
assessed and corrected.
The main advantages of our NEWS/NEWS2 models
are that they are designed to incorporate data that are
already available in the patient’s electronic health record
and so place no additional data collection or computa-
tional burden on clinicians and can also be readily auto-
mated. Nonetheless, we emphasize that our NEWS/
NEWS2 models are not designed to replace clinical
judgement. They are intended and designed to support,
not subvert, the clinical decision-making process and
can be always overridden by clinical concern [5, 23]. The
working hypothesis for our models is that their use may
enhance situational awareness of COVID-19 by process-
ing information already available without impeding the
workflow of clinical staff, especially as our approach of-
fers a faster and less expensive assessment of COVID-19
















M0 No 0.09 0.11 -14.7 0.65 (0.62 to 0.69) 0.19 (0.06 to 0.32) 0.72 (0.53 to 0.91)
M1 No 0.09 0.12 -12.4 0.67 (0.64 to 0.7) 0.18 (0.05 to 0.31) 0.81 (0.63 to 0.99)
M2 No 0.09 0.16 -8.2 0.72 (0.69 to 0.75) 0.19 (0.06 to 0.32) 0.78 (0.65 to 0.91)
M0 Yes 0.11 0.14 0.5 0.65 (0.62 to 0.69) - 0.72 (0.53 to 0.91)
M1 Yes 0.11 0.14 1.9 0.67 (0.64 to 0.7) - 0.81 (0.63 to 0.99)
M2 Yes 0.10 0.18 5.2 0.72 (0.69 to 0.75) - 0.78 (0.65 to 0.91)
M0` No 0.09 0.12 -14.2 0.65 (0.61 to 0.68) 0.18 (0.06 to 0.31) 0.69 (0.51 to 0.87)
M1` No 0.09 0.12 -12.2 0.67 (0.64 to 0.7) 0.17 (0.05 to 0.30) 0.78 (0.60 to 0.96)
M2` No 0.09 0.17 -6.9 0.72 (0.69 to 0.75) 0.18 (0.05 to 0.31) 0.76 (0.64 to 0.89)
M0` Yes 0.11 0.14 0.2 0.65 (0.61 to 0.68) - 0.69 (0.51 to 0.87)
M1` Yes 0.11 0.14 1.3 0.67 (0.64 to 0.7) - 0.78 (0.60 to 0.96)
M2` Yes 0.10 0.19 5.5 0.72 (0.69 to 0.75) - 0.76 (0.64 to 0.89)
ARD absolute risk difference, CIs confidence intervals
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risk than current laboratory tests. This may be more
practical to use in low resource settings or where large
numbers of people are to be assessed.
There are limitations in relation to our study. We
identified COVID-19 based on ICD-10 code ‘U071’
which was determined by clinical judgment and/or swab
test results and so our findings are constrained by the
accuracy of these methods [24, 25]. Moreover, we do not
have the timing of diagnosis in our data and so we are
unable to determine if patients arrived with COVID-19.
Our two hospitals are part of the same NHS Trust and
this may undermine the generalisability of our findings,
and so further external validation may be worthwhile.
Another issue related to generalisability is to determine
the extent to which mass vaccinations for COVID-19
impact on the accuracy of our models. Finally, an
Fig. 1 Receiver Operating Characteristic curve for NEWS models (M0,M1,M2) and NEWS2 models (M0’,M1’,M2’) in predicting the risk of COVID-19
following admission in the validation dataset after correcting for calibration-in-the-large. Note: predicted probability at NEWS or NEWS2 threshold≥
5 (sensitivity, specificity) is shown for all models
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Table 3 Sensitivity analysis of NEWS (M0, M1, M2) and NEWS2 models (M0’, M1’, M2’) for predicting the risk of COVID at threshold
NEWS/NEWS2 ≥ 5 (predicted probability of model M0 = 0.130 and M0’ = 0.116 using development dataset) for validation dataset
after correcting the calibration-in-the-large
Model Number of positive cases
identified by model
Sensitivity% Specificity% PPV NPV LR+ LR-
M0 474 32.9 (27.4 to 38.7) 82.9 (81.3 to 84.5) 19.2 (15.7 to 23) 90.9 (89.6 to 92.1) 1.9 (1.6 to 2.3) 0.8 (0.7 to 0.9)
M1 600 44 (38.1 to 50.1) 78.7 (76.9 to 80.4) 20.3 (17.2 to 23.8) 91.9 (90.6 to 93.1) 2.1 (1.8 to 2.4) 0.7 (0.6 to 0.8)
M2 607 51.6 (45.6 to 57.6) 79.3 (77.6 to 81) 23.6 (20.2 to 27.1) 93 (91.8 to 94.1) 2.5 (2.2 to 2.9) 0.6 (0.5 to 0.7)
M0` 681 44.4 (38.5 to 50.5) 75.1 (73.3 to 76.9) 18.1 (15.2 to 21.2) 91.6 (90.3 to 92.9) 1.8 (1.5 to 2.1) 0.7 (0.7 to 0.8)
M1` 781 52.7 (46.6 to 58.7) 71.7 (69.8 to 73.5) 18.7 (16 to 21.6) 92.5 (91.1 to 93.7) 1.9 (1.6 to 2.1) 0.7 (0.6 to 0.7)
M2` 692 57 (51 to 62.9) 76.2 (74.4 to 77.9) 22.8 (19.8 to 26.1) 93.5 (92.3 to 94.6) 2.4 (2.1 to 2.7) 0.6 (0.5 to 0.6)
PPV Positive Predictive Value, NPV Negative Predictive Value, LR+ Positive Likelihood Ratio, LR- Negative Likelihood Ratio
Fig. 2 External validation of NEWS models (M0, M1, M2) for predicting the risk of COVID-19. NB: We limit the risk of COVID-19 to 0.30 for
visualisation purposes because beyond this point, we have few patients. The grey solid line shows ideal calibration. The black solid line shows the
observed calibration along with 95 % confidence intervals in black dashed lines
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Fig. 3 External validation of NEWS2 models (M0’, M1’, M2’) for predicting the risk of COVID-19. NB: We limit the risk of COVID-19 to 0.30 for
visualisation purposes because beyond this point, we have few patients. The grey solid line shows ideal calibration. The black solid line shows the
observed calibration along with 95 % confidence intervals in black dashed lines
Fig. 4 Net Benefit for NEWS models (M0, M1, M2) and NEWS2 models (M0’,M1’,M2’) in predicting the risk of COVID-19 in the validation dataset
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important next phase of this work is to field-test our
models by carefully engineering them into routine clin-
ical practice [26, 27] to see if they do support the earlier
detection and care of COVID-19 in emergency medical
patients without unintended adverse consequences.
Conclusions
NEWS model M2 and NEWS2 model M2’ appear to
provide reasonably accurate predictions of the risk of
COVID-19 using routinely collected on-admission
NEWS/NEWS2 datasets. The extent to which these
models are clinically useful as an early warning system
for COVID-19 at the time of admission should be
studied.
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paring NEWS models (M0, M1, M2) and NEWS2 models (M0’,M1’,M2’) for
predicting the risk of COVID on admission for development dataset. Fig-
ure S7. Receiver Operating Characteristic curve for NEWS models (M0,
M1, M2) and NEWS2 models (M0’,M1’,M2’) in predicting the risk of COVID-
19 in the development dataset. Table S6. Sensitivity analysis of NEWS
models (M0, M1, M2) and NEWS2 models (M0’, M1’, M2’) for predicting
the risk of COVID at threshold ≥5 of NEWS (predicted probability of
model M0 = 0.130) and NEWS2 (predicted probability of model M0’ =
0.116) for development dataset. Figure S8. Net Benefit for NEWS models
(M0, M1, M2) and NEWS2 models (M0’,M1’,M2’) in predicting the risk of
COVID-19 in the development dataset.
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